Antiprothrombin antibodies: A comparative analysis of homemade and commercial methods. A collaborative study by the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA)

Clinical and Experimental Rheumatology

Volumn 25, Issue 2, 2007, Pages 268-274

  Tincani, Angela ^a   Morozzi, Gabriella ^b   Afeltra, Afeltra ^c   Alessandri, Cristiano ^d   Allegri, Flavio ^a   Bistoni, Onelia ^e   Bizzaro, Nicola ^f   Caccavo, Domenico ^c,o   Galeazzi, Mauro ^b   Gerli, Roberto ^e   Giovannelli, Luigi ^g   Longobardo, Giovanni ^h   Lotzniker, Milvia ⁱ   Malacarne, Fabio ^a   Migliorini, Paola ^h   Parodi, Aurora ^j   Pregnolato, Francesca ^k   Radice, Antonella ^l   Riccieri, Valeria ^d   Ruffelli, Marina ^m   Sinico, Renato Alberto ^l   Tozzoli, Renato ^f   Villalta, Danilo ⁿ   Marcolongo, Roberto ^b   Meroni, Pierluigi ^k   more..

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

^c UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY OF PERUGIA   (Italy)

^f Ospedale Civile   (Italy)

^g BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^h UNIVERSITY OF PISA   (Italy)

ⁱ Laboratorio Analisi Ospidale Civile de Legnano   (Italy)

^j UNIVERSITY OF GENOA   (Italy)

^k UNIVERSITY OF MILAN   (Italy)

^l SAN CARLO BORROMEO HOSPITAL   (Italy)

^m LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

ⁿ Immunologia Clinica e Virologia   (Italy)

^o UNIVERSITY OF BARI   (Italy)

more..

Author keywords

Anticardiolipin antibodies; Antiphospholipid antibodies; Antiphospholipid syndrome; Antiprothrombin antibodies; Lupus anticoagulant

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PROTHROMBIN ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CONTROLLED STUDY; DIAGNOSIS, MEASUREMENT AND ANALYSIS; DIAGNOSTIC ACCURACY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; PRIORITY JOURNAL; REPRODUCIBILITY; RHEUMATOID ARTHRITIS;

ANTIBODIES, ANTI-IDIOTYPIC; ANTIPHOSPHOLIPID SYNDROME; ARTHRITIS, RHEUMATOID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS COAGULATION INHIBITOR; PROTHROMBIN; REPRODUCIBILITY OF RESULTS;

EID: 34249805121     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. BEVERS EM, GALLI M, BARBUI T, COMFURIUS P, ZWAAL RF: Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991; 66: 629-32.
2. OOSTING JD, DERKSEN RHWM, BOBBINK IWG, HACKENG TM, BOUMA BN, DE GROOT PG: Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: An explanation for their pathogenic mechanism? Blood 1993; 81: 2618-25.
3. ARVIEUX J, DARNIGE L, CARON C, REBER G, BENSA JC, COLOMB MG: Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemost 1995; 74:1120-5.
4. HORBACH DA, VAN OORT E, DONDERS RC, DERKSEN RH, DE GROOT PG: Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies. Thromb Haemost 1996; 76: 916-24.
5. PUURUNEN M, VAARALA O, JULKUNEN H, AHO K, PALOSUO T: Antibodies to phospholipid-binding plasma proteins and occurrence of thrombosis in patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1996; 80: 16-22.
6. GALLI M AND BARBUI T: Dntiprothrombin antibodies: detection and clinical significance in the antiphospholipid syndrome. Blood 1999; 93: 2149-57.
7. BERTOLACCINI ML, ATSUMI T, KHAMASHTA MA, AMENGUAL O, HUGHES GR: Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus. J Rheumatol 1998; 25: 1104-8.
8. MUSIAL J, SWADZBA J, MOTYL A, IWANIEC T: Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis. J Rheumatol 2003; 30: 723-30.
9. VON LANDENBERG P, MATTHIAS T, ZAECH J et al.: Antiprothrombin antibodies are associated with pregnancy loss in patients with the antiphospholipid syndrome. Am J Reprod Immunol 2003; 49: 51-6.
10. NOJIMA J, KURATSUNE H, SUEHISA E et al.: Anti-prothrombin antibodies combined with lupus anti-coagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus. Br J Haematol 2001; 114: 647-54.
11. GUERIN J, SMITH O, WHITE B, SWEETMAN G, FEIGHERY C, JACKSON J: Antibodies to prothrombin in antiphospholipid syndrome and inflammatory disorders. Br J Haematol 1998; 102: 896-902.
12. PENGO V, BIASIOLO A, BROCCO T, TONETTO S, RUFFATTI A: Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipids-reactive antibodies. Thromb Haemost 1996; 75: 721-4.
13. FORASTIERO RR, MARTINUZZO ME, CERRATO GS, KORDICH LC, CARRERAS LO: Relationship of anti beta2-glycoprotein I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies. Thromb Haemost 1997; 78: 1008-14.
14. MUNOZ-RODRIGUEZ FJ, REVERTER JC, FONT J et al.: Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome. Haematologica 2000; 85: 632-7.
15. GALLI M, LUCIANI D, BERTOLINI G, BARBUI T: Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood 2003; 102: 2717-23.
16. HAJ-YAHJA S, SHERER Y, BLANK M, KAETSU H, SMOLINSKY A, SHOENFELD Y: Anti-prothrombin antibodies cause thrombosis in a novel qualitative ex vivo animal model. Lupus 2003; 12: 364-9.
17. ROUBEY RA, HOFFMAN M: From antiphospholipid syndrome to antibody-mediated thrombosis. Lancet 1997; 350: 1491-3.
18. AMENGUAL O, ATSUMI T, KOIKE T: Specificities, properties, and clinical significance of antiprothrombin antibodies. Arthritis Rheum 2003; 48: 886-95.
19. ATSUMI T, IEKO M, BERTOLACCINI ML et al.: Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum 2000; 43: 1982-93.
20. BERTOLACCINI ML, ATSUMI T, KOIKE T, HUGHES GR, KHAMASHTA MA: Antiprothrombin antibodies detected in two different assay systems. Prevalence and clinical significance in systemic lupus erythematosus. Thromb Haemost 2005; 93: 289-97.
21. MIYAKIS S, LOCKSHIN MD, ATSUMI T et al.: International consensus statement on an up-date of the preliminary classification criteria for antiphospholipid syndrome (APS). J Thromb Haemost 2005; 3: 1-12.
22. MATSUDA J, SAITOH N, GOTOH M, KAWASUGI K, GOHCHI K, TSUKAMOTO M: Phosphatidyl serine-dependent antiprothrombin antibody is exclusive to patients with lupus anticoagulant. Br J Rheumatol 1996; 35: 589-91.
23. ROUBEY RA: Autoantibodies to phospholipid binding Alasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies. Blood 1994; 84: 2854-67.
24. SIMMELINK MJ DERKSEN RH, ARNOUT J, DE GROOT PG: A simple method to discriminate between beta2-glycoprotein I- and prothombin-dependent lupus anticoagulants. J Thromb Haemost 2003; 1: 740-7.
25. VIARD JP, AMOURA Z, BACH JF: Association of anti-beta2 glycoprotein I anibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 1992; 93: 181-6.
26. REBER G, SCHOUSBOE I, TINCANI A et al.: Inter-laboratory variability of anti-beta-2-glycoprotein I measurement. A collaborative study in the frame of the European Forum on Antiphospholipid Antibodies Standardization Group. Thromb Haemost 2002; 88: 66-73.